Single patient study to evaluate genomic abnormalities leading to pancreatic cancer in a patient with melanoma and receiving a BRAF inhibitor
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The purpose of this study is to evaluate the DNA changes in a patient's resected pancreatic cancer and melanoma tumors to understand the relationship between those two tumors and the treatment the patient had received in the past.
Description
The purpose of this study is to evaluate the DNA changes in the patient?s resected pancreatic cancer and melanoma tumors to understand the relationship between these two tumors and the treatment the patient had received in the past.
Details
| Condition | Pancreatic Cancer |
|---|---|
| Age | 100years or below |
| Clinical Study Identifier | TX4080 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.